Table 4.

Risk of recurrent ischemic stroke at 90 days after presenting event adjusted for age and sex, Hazard Ratio, HR(95 % Confidence Intervals) per increase in decile.

Biomarkers	All Patients	TIA	Stroke
Inflammatory markers
IL-6	1.12(1.01-1.24) p=0.035	1.07(0.85-1.35)	1.10(0.98-1.23)
CRP	1.16(1.02-1.30) p=0.019	1.02(0.78-1.33)	1.16(1.01-1.34) p=0.042
NGAL	1.02(0.92-1.13)	1.03(0.81-1.31)	0.99(0.88-1.12)
TNFR-1	1.01(0.91-1.12)	0.90(0.71-1.16)	1.01(0.90-1.13)
Cardiac or Neuronal function/injury
hFABP	1.04(0.93-1.16)	0.89(0.68-1.18)	1.05(0.92-1.19)
NSE	1.04(0.95-1.15)	0.93(0.74-1.18)	1.05(0.94-1.17)
BDNF	1.02(0.93-1.12)	1.11(0.88-1.41)	0.98(0.89-1.09)
Thrombotic markers
TM	1.01(0.91-1.12)	0.99(0.78-1.24)	1.02(0.91-1.14)
Fibrinogen	1.10(0.98-1.23)	0.99(0.76-1.28)	1.11(0.97-1.26)
P-selectin	1.04(0.94-1.14)	1.31(1.02-1.66) p=0.028	0.96(0.86-1.07)
D-dimer	1.01(0.89-1.15)	1.06(0.81-1.41)	0.97(0.84-1.13)
VWF	0.98(0.87-1.10)	0.96(0.73-1.26)	0.96(0.84-1.09)
Protein Z	0.98(0.88-1.10)	0.80(0.60-1.07)	1.03(0.91-1.17)
Anti atherogenic antibody
Anti PC	0.91(0.79-1.05)	0.95(0.70-1.29)	0.90(0.77-1.06)